The global Female Infertility Medications market was valued at 2614 million in 2024 and is projected to reach US$ 4075 million by 2031, at a CAGR of 6.7% during the forecast period.
Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Female Infertility Medications companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Female Infertility Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Female Infertility Medications. This report contains market size and forecasts of Female Infertility Medications in global, including the following market information:
Global Female Infertility Medications market revenue, 2020-2025, 2026-2031, ($ millions)
Global top five Female Infertility Medications companies in 2024 (%)
Total Market by Segment:
Global Female Infertility Medications market, by Type, 2020-2025, 2026-2031 ($ millions)
Global Female Infertility Medications market segment percentages, by Type, 2024 (%)
Gonadotropins
Aromatase Inhibitors
Selective Estrogen Receptor Modulators (SERMs)
Dopamine Agonists
Others
Global Female Infertility Medications market, by Application, 2020-2025, 2026-2031 ($ millions)
Global Female Infertility Medications market segment percentages, by Application, 2024 (%)
Hospital Pharmacy
Specialty & Retail Pharmacy
Online Pharmacy
Global Female Infertility Medications market, by region and country, 2020-2025, 2026-2031 ($ millions)
Global Female Infertility Medications market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Female Infertility Medications revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Female Infertility Medications revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Ferring
MSD
LIVZON
Abbott
Bayer Zydus Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Female Infertility Medications, market overview.
Chapter 2: Global Female Infertility Medications market size in revenue.
Chapter 3: Detailed analysis of Female Infertility Medications company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Female Infertility Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Female Infertility Medications Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Female Infertility Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Female Infertility Medications Overall Market Size
2.1 Global Female Infertility Medications Market Size: 2024 VS 2031
2.2 Global Female Infertility Medications Market Size, Prospects & Forecasts: 2020-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Female Infertility Medications Players in Global Market
3.2 Top Global Female Infertility Medications Companies Ranked by Revenue
3.3 Global Female Infertility Medications Revenue by Companies
3.4 Top 3 and Top 5 Female Infertility Medications Companies in Global Market, by Revenue in 2024
3.5 Global Companies Female Infertility Medications Product Type
3.6 Tier 1, Tier 2, and Tier 3 Female Infertility Medications Players in Global Market
3.6.1 List of Global Tier 1 Female Infertility Medications Companies
3.6.2 List of Global Tier 2 and Tier 3 Female Infertility Medications Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Female Infertility Medications Market Size Markets, 2024 & 2031
4.1.2 Gonadotropins
4.1.3 Aromatase Inhibitors
4.1.4 Selective Estrogen Receptor Modulators (SERMs)
4.1.5 Dopamine Agonists
4.1.6 Others
4.2 Segmentation by Type - Global Female Infertility Medications Revenue & Forecasts
4.2.1 Segmentation by Type - Global Female Infertility Medications Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Female Infertility Medications Revenue, 2026-2031
4.2.3 Segmentation by Type - Global Female Infertility Medications Revenue Market Share, 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Female Infertility Medications Market Size, 2024 & 2031
5.1.2 Hospital Pharmacy
5.1.3 Specialty & Retail Pharmacy
5.1.4 Online Pharmacy
5.2 Segmentation by Application - Global Female Infertility Medications Revenue & Forecasts
5.2.1 Segmentation by Application - Global Female Infertility Medications Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Female Infertility Medications Revenue, 2026-2031
5.2.3 Segmentation by Application - Global Female Infertility Medications Revenue Market Share, 2020-2031
6 Sights by Region
6.1 By Region - Global Female Infertility Medications Market Size, 2024 & 2031
6.2 By Region - Global Female Infertility Medications Revenue & Forecasts
6.2.1 By Region - Global Female Infertility Medications Revenue, 2020-2025
6.2.2 By Region - Global Female Infertility Medications Revenue, 2026-2031
6.2.3 By Region - Global Female Infertility Medications Revenue Market Share, 2020-2031
6.3 North America
6.3.1 By Country - North America Female Infertility Medications Revenue, 2020-2031
6.3.2 United States Female Infertility Medications Market Size, 2020-2031
6.3.3 Canada Female Infertility Medications Market Size, 2020-2031
6.3.4 Mexico Female Infertility Medications Market Size, 2020-2031
6.4 Europe
6.4.1 By Country - Europe Female Infertility Medications Revenue, 2020-2031
6.4.2 Germany Female Infertility Medications Market Size, 2020-2031
6.4.3 France Female Infertility Medications Market Size, 2020-2031
6.4.4 U.K. Female Infertility Medications Market Size, 2020-2031
6.4.5 Italy Female Infertility Medications Market Size, 2020-2031
6.4.6 Russia Female Infertility Medications Market Size, 2020-2031
6.4.7 Nordic Countries Female Infertility Medications Market Size, 2020-2031
6.4.8 Benelux Female Infertility Medications Market Size, 2020-2031
6.5 Asia
6.5.1 By Region - Asia Female Infertility Medications Revenue, 2020-2031
6.5.2 China Female Infertility Medications Market Size, 2020-2031
6.5.3 Japan Female Infertility Medications Market Size, 2020-2031
6.5.4 South Korea Female Infertility Medications Market Size, 2020-2031
6.5.5 Southeast Asia Female Infertility Medications Market Size, 2020-2031
6.5.6 India Female Infertility Medications Market Size, 2020-2031
6.6 South America
6.6.1 By Country - South America Female Infertility Medications Revenue, 2020-2031
6.6.2 Brazil Female Infertility Medications Market Size, 2020-2031
6.6.3 Argentina Female Infertility Medications Market Size, 2020-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Female Infertility Medications Revenue, 2020-2031
6.7.2 Turkey Female Infertility Medications Market Size, 2020-2031
6.7.3 Israel Female Infertility Medications Market Size, 2020-2031
6.7.4 Saudi Arabia Female Infertility Medications Market Size, 2020-2031
6.7.5 UAE Female Infertility Medications Market Size, 2020-2031
7 Companies Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Female Infertility Medications Major Product Offerings
7.1.4 Merck Female Infertility Medications Revenue in Global Market (2020-2025)
7.1.5 Merck Key News & Latest Developments
7.2 Ferring
7.2.1 Ferring Corporate Summary
7.2.2 Ferring Business Overview
7.2.3 Ferring Female Infertility Medications Major Product Offerings
7.2.4 Ferring Female Infertility Medications Revenue in Global Market (2020-2025)
7.2.5 Ferring Key News & Latest Developments
7.3 MSD
7.3.1 MSD Corporate Summary
7.3.2 MSD Business Overview
7.3.3 MSD Female Infertility Medications Major Product Offerings
7.3.4 MSD Female Infertility Medications Revenue in Global Market (2020-2025)
7.3.5 MSD Key News & Latest Developments
7.4 LIVZON
7.4.1 LIVZON Corporate Summary
7.4.2 LIVZON Business Overview
7.4.3 LIVZON Female Infertility Medications Major Product Offerings
7.4.4 LIVZON Female Infertility Medications Revenue in Global Market (2020-2025)
7.4.5 LIVZON Key News & Latest Developments
7.5 Abbott
7.5.1 Abbott Corporate Summary
7.5.2 Abbott Business Overview
7.5.3 Abbott Female Infertility Medications Major Product Offerings
7.5.4 Abbott Female Infertility Medications Revenue in Global Market (2020-2025)
7.5.5 Abbott Key News & Latest Developments
7.6 Bayer Zydus Pharma
7.6.1 Bayer Zydus Pharma Corporate Summary
7.6.2 Bayer Zydus Pharma Business Overview
7.6.3 Bayer Zydus Pharma Female Infertility Medications Major Product Offerings
7.6.4 Bayer Zydus Pharma Female Infertility Medications Revenue in Global Market (2020-2025)
7.6.5 Bayer Zydus Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Female Infertility Medications Market Opportunities & Trends in Global Market
Table 2. Female Infertility Medications Market Drivers in Global Market
Table 3. Female Infertility Medications Market Restraints in Global Market
Table 4. Key Players of Female Infertility Medications in Global Market
Table 5. Top Female Infertility Medications Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Female Infertility Medications Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Female Infertility Medications Revenue Share by Companies, 2020-2025
Table 8. Global Companies Female Infertility Medications Product Type
Table 9. List of Global Tier 1 Female Infertility Medications Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Female Infertility Medications Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type – Global Female Infertility Medications Revenue, (US$, Mn), 2024 & 2031
Table 12. Segmentation by Type - Global Female Infertility Medications Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Female Infertility Medications Revenue (US$, Mn), 2026-2031
Table 14. Segmentation by Application– Global Female Infertility Medications Revenue, (US$, Mn), 2024 & 2031
Table 15. Segmentation by Application - Global Female Infertility Medications Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Female Infertility Medications Revenue, (US$, Mn), 2026-2031
Table 17. By Region– Global Female Infertility Medications Revenue, (US$, Mn), 2024 & 2031
Table 18. By Region - Global Female Infertility Medications Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Female Infertility Medications Revenue, (US$, Mn), 2026-2031
Table 20. By Country - North America Female Infertility Medications Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Female Infertility Medications Revenue, (US$, Mn), 2026-2031
Table 22. By Country - Europe Female Infertility Medications Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Female Infertility Medications Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Asia Female Infertility Medications Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Female Infertility Medications Revenue, (US$, Mn), 2026-2031
Table 26. By Country - South America Female Infertility Medications Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Female Infertility Medications Revenue, (US$, Mn), 2026-2031
Table 28. By Country - Middle East & Africa Female Infertility Medications Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Female Infertility Medications Revenue, (US$, Mn), 2026-2031
Table 30. Merck Corporate Summary
Table 31. Merck Female Infertility Medications Product Offerings
Table 32. Merck Female Infertility Medications Revenue (US$, Mn) & (2020-2025)
Table 33. Merck Key News & Latest Developments
Table 34. Ferring Corporate Summary
Table 35. Ferring Female Infertility Medications Product Offerings
Table 36. Ferring Female Infertility Medications Revenue (US$, Mn) & (2020-2025)
Table 37. Ferring Key News & Latest Developments
Table 38. MSD Corporate Summary
Table 39. MSD Female Infertility Medications Product Offerings
Table 40. MSD Female Infertility Medications Revenue (US$, Mn) & (2020-2025)
Table 41. MSD Key News & Latest Developments
Table 42. LIVZON Corporate Summary
Table 43. LIVZON Female Infertility Medications Product Offerings
Table 44. LIVZON Female Infertility Medications Revenue (US$, Mn) & (2020-2025)
Table 45. LIVZON Key News & Latest Developments
Table 46. Abbott Corporate Summary
Table 47. Abbott Female Infertility Medications Product Offerings
Table 48. Abbott Female Infertility Medications Revenue (US$, Mn) & (2020-2025)
Table 49. Abbott Key News & Latest Developments
Table 50. Bayer Zydus Pharma Corporate Summary
Table 51. Bayer Zydus Pharma Female Infertility Medications Product Offerings
Table 52. Bayer Zydus Pharma Female Infertility Medications Revenue (US$, Mn) & (2020-2025)
Table 53. Bayer Zydus Pharma Key News & Latest Developments
List of Figures
Figure 1. Female Infertility Medications Product Picture
Figure 2. Female Infertility Medications Segment by Type in 2024
Figure 3. Female Infertility Medications Segment by Application in 2024
Figure 4. Global Female Infertility Medications Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Female Infertility Medications Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Female Infertility Medications Revenue: 2020-2031 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Female Infertility Medications Revenue in 2024
Figure 9. Segmentation by Type – Global Female Infertility Medications Revenue, (US$, Mn), 2024 & 2031
Figure 10. Segmentation by Type - Global Female Infertility Medications Revenue Market Share, 2020-2031
Figure 11. Segmentation by Application – Global Female Infertility Medications Revenue, (US$, Mn), 2024 & 2031
Figure 12. Segmentation by Application - Global Female Infertility Medications Revenue Market Share, 2020-2031
Figure 13. By Region - Global Female Infertility Medications Revenue Market Share, 2020-2031
Figure 14. By Country - North America Female Infertility Medications Revenue Market Share, 2020-2031
Figure 15. United States Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 16. Canada Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 17. Mexico Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 18. By Country - Europe Female Infertility Medications Revenue Market Share, 2020-2031
Figure 19. Germany Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 20. France Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 21. U.K. Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 22. Italy Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 23. Russia Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 24. Nordic Countries Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 25. Benelux Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 26. By Region - Asia Female Infertility Medications Revenue Market Share, 2020-2031
Figure 27. China Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 28. Japan Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 29. South Korea Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 30. Southeast Asia Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 31. India Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 32. By Country - South America Female Infertility Medications Revenue Market Share, 2020-2031
Figure 33. Brazil Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 34. Argentina Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 35. By Country - Middle East & Africa Female Infertility Medications Revenue Market Share, 2020-2031
Figure 36. Turkey Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 37. Israel Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 38. Saudi Arabia Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 39. UAE Female Infertility Medications Revenue, (US$, Mn), 2020-2031
Figure 40. Merck Female Infertility Medications Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Ferring Female Infertility Medications Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. MSD Female Infertility Medications Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. LIVZON Female Infertility Medications Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Abbott Female Infertility Medications Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Bayer Zydus Pharma Female Infertility Medications Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
